Skip to main content

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Introduction

On Thursday, U.S. District Judge Vince Chhabria, overseeing the Roundup multidistrict litigation docket, indicated that he might lift the stay on litigation after hearing concerns from plaintiffs' attorneys over the uncertainty of the more than $10 billion deal.

In June, the German chemical and pharmaceutical giant, Bayer, indicated that it would pay more than $10 billion to settle about 75% of the lawsuits claiming that its herbicide Roundup was the cause of non-Hodgkin’s lymphoma. Following the announcement of the deal, which is managed by mediator Kenneth Feinberg, Judge Chhabria halted the multidistrict litigation for the settlement process.

In July, Judge Chhabria had raised concerns over one part of the deal, which includes a plan for handling future claims brought by the consumers who develop non-Hodgkin’s lymphoma, after using the weedkiller. He indicated that he is skeptical of the propriety and fairness of the proposed settlement, and is tentatively inclined to deny the motion.

In the recent hearing, Judge Chhabria stated that he received several confidential letters alleging the manufacturer of reneging on its deal with the plaintiffs. After hearing arguments from both parties, he concluded that he would not lift the stay expressing his confidence in Feinberg’s ability to reach a resolution in 30 days. But he also noted that the parties should also start reworking on getting the litigation back on track as he won't extend the stay any further. The parties have been asked to be prepared by the next case management conference that is scheduled for September 24.

Roundup, one of the most commonly and widely used weedkillers, contains Glyphosate as one of its main ingredients. Glyphosate is a systemic and broad-spectrum herbicide that was patented by a U.S. company, Monsanto, in 1970. Bayer acquired Monsanto on June 7, 2018.

Currently, Bayer is facing more than 125,000 Roundup lawsuits, and the company has acknowledged the filing of 52,500 lawsuits. The lawsuits are consolidated under MDL No. 2741 in the U.S. District Court for the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!